Cholesterol-lowering drugs as cardioprotective agents

Research output: Contribution to journalArticle

13 Scopus citations

Abstract

A detailed overview of the various forms of hyperlipidemia/dysllpidemia that constitute a major risk factor for coronary heart disease and a detailed discussion of the various types of cholesterol-lowering drugs are presented. The importance of identifying the type of dysllpidemia with respect to the choice of treatment is emphasized, as is the use of nonpharmacologic intervention, i.e., diet, exercise, and weight loss. The appropriate use and benefits of bile acid sequestrants, nicotinic acid, fibric acids, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, and probucol are individually discussed, whereas nonpharmacologic approaches used in conjunction with the drugs are recommended emphatically.

Original languageEnglish (US)
Pages (from-to)I27-I32
JournalThe American journal of cardiology
Volume70
Issue number21
DOIs
StatePublished - Dec 21 1992

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Cholesterol-lowering drugs as cardioprotective agents'. Together they form a unique fingerprint.

  • Cite this